---
title: 'Senior Contracts Manager at Immunome, Inc.'
canonical: 'https://feeny.ai/job/senior-contracts-manager-immunome-inc-bothell-washington-3bmwb4ke189c'
type: 'job'
last_seen: '2026-09-05'
---

# Senior Contracts Manager at Immunome, Inc.

- **Company:** Immunome, Inc.
- **Location:** Bothell Washington, United States
- **Compensation:** $161k–$191k
- **Posted:** 2026-09-02
- **Last confirmed live:** 2026-09-05
- **Apply:** https://job-boards.greenhouse.io/immunomeinc/jobs/5413776008

## Job description

Company Overview

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

Position Overview

Immunome is seeking a highly organized, proactive, and detail-oriented Contracts Manager to join its legal team. This role is ideal for a legal professional who excels at managing contract lifecycles while also being able to provide broader support across corporate, transactional, and compliance functions. The ideal candidate will have experience in the biotech or pharmaceutical industries and be comfortable supporting cross-functional teams in a fast-paced, dynamic environment.

## Responsibilities

Contracts Management

- Serve as the primary administrator for the company’s contract lifecycle management (CLM) system (e.g., Ironclad), including contract intake, routing, tracking, and archiving.
- Draft, review, and coordinate the execution of standard agreements, including NDAs, consulting agreements, SOWs, CTAs, MTAs, and vendor agreements.
- Identify and assess legal and business risks and escalate as necessary.
- Ensure all contractual activities comply with internal policies, applicable laws and regulations, and industry best practices.
- Maintain accurate records of contract status, key terms, and renewal/termination dates.
- Collaborate with internal stakeholders (R&D, Finance, Clinical) to ensure timely and compliant contract processing, including renewal or cancellation of existing contracts.
- Assist with improving and maintaining contract templates, playbooks, and process workflows.

## Qualifications

- Bachelor’s degree required. Paralegal certificate or JD, strongly preferred.
- A minimum of 5 years of contracts management experience, biotechnology or life sciences industry experience is required.

Knowledge and Skills

- Deep understanding of contract structures, terms, and risk assessment.
- Proficiency with contract lifecycle management tools (e.g., Ironclad, ContractWorks).
- Exceptional organizational and time management skills.
- Ability to manage multiple priorities and deadlines.
- Strong interpersonal, communication, and client service skills; capable of working collaboratively across departments.
- Commitment to integrity and ethical conduct and ability to protect confidential information.
- Familiarity with software tools like DocuSign, Microsoft Office Suite, and Adobe Acrobat.
- Experience supporting clinical trial or research-related contracts, preferred.

Washington State Pay Range $160,776—$190,776 USD

E/E/O

Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

E-Verify

Immunome, Inc. is a participant in E-Verify. Please review the following notices: [E-Verify Participation Poster](https://immunome.box.com/s/bopxukipfidxjscs4bjxt75f90bvpppk) | https://immunome.box.com/s/r51g9subw1wqni9xkutbl6up635sjr8e | https://immunome.box.com/s/r3ekbimwh988my9vzl76tnlbg60zvh9u.

## About Immunome, Inc.

## Company Overview
- **One-liner**: Immunome is a clinical-stage oncology company developing first-in-class and best-in-class targeted cancer therapies, with a primary focus on antibody-drug conjugates (ADCs).
- **Entity Type**: Public (Nasdaq: IMNM)
- **Headquarters**: Bothell, Washington, United States
- **Founded**: The company was formed through a merger of Morphimmune and Immunome in October 2023.
- **Founders**: The company is led by Clay Siegall, Ph.D. (Chairman, CEO, and President), who co-founded Seagen. The original Immunome entity was founded earlier, but the current company structure dates to the 2023 merger.

## Core Business
- Primary industry/industries: Biotechnology, Oncology, Drug Discovery & Development
- Target customers: Patients with cancer, healthcare providers, and clinical trial sites. The company is a B2B/B2C entity in the healthcare and life sciences space.
- Mission or purpose statement: "Our mission is to improve outcomes for cancer patients by advancing and expanding a portfolio of first-in-class and best-in-class therapeutic candidates." [immunome.com](https://immunome.com/)

## Products & Services
- **Varegacestat (formerly AL102)**: A late-clinical stage gamma secretase inhibitor for the treatment of desmoid tumors. The company submitted a New Drug Application (NDA) to the U.S. FDA in April 2026. [investors.immunome.com](https://investors.immunome.com/)
- **IM-1021**: A ROR1-targeted antibody-drug conjugate (ADC) currently in a Phase 1 trial.
- **IM-3050**: A FAP-targeted radioligand which received IND clearance in Q1 2025.
- **Preclinical ADC Pipeline (IM-1617, IM-1340, IM-1335)**: ADCs pursuing undisclosed targets with expression in multiple solid tumors. IM-1617 had its first patient dosed in a Phase 1 trial in June 2026. [investors.immunome.com](https://investors.immunome.com/)

## Market Standing
- **Valuation/Market Cap**: Not publicly available in the search results. As a public company, this fluctuates. (Check recent filings for current data).
- **Key Metric**: The company is pre-revenue (clinical-stage) and has raised significant capital. Since the 2023 merger, CEO Clay Siegall has raised $355 million in equity financings. [immunome.com](https://immunome.com/about/)
- **Notable Investors/Partners**: The company is publicly traded. Key leadership previously worked at Seagen (acquired by Pfizer for $43 billion).
- **Growth Signals**: The company is rapidly advancing its pipeline. Key milestones include the NDA submission for varegacestat, first patient dosed for IM-1617, and positive Phase 3 data presented at ASCO 2026. The company currently lists 32 open positions on its careers page, indicating strong hiring momentum. [job-boards.greenhouse.io](http://job-boards.greenhouse.io/immunomeinc)

## Competitive Advantages
- **World-Class Leadership**: The executive team, led by Seagen co-founder Clay Siegall, has deep experience in designing, developing, and commercializing blockbuster ADCs (ADCETRIS, PADCEV, TIVDAK, TUKYSA). [immunome.com](https://immunome.com/about/)
- **Proprietary ADC Platform**: A systematic, data-driven process for optimizing antibodies, linkers, and payloads to create differentiated ADCs. [immunome.com](https://immunome.com/)
- **Near-Term Catalyst**: The NDA submission for varegacestat provides a potential near-term commercial opportunity.
- **Strong Financial Backing**: Raised $355M in equity since the merger, providing a solid runway for pipeline advancement.

## Strategic Focus
- **Advancing the Pipeline**: The primary focus is on executing clinical trials for varegacestat (Phase 3), IM-1021 (Phase 1), and IM-3050 (Phase 1), and advancing preclinical ADCs into the clinic.
- **Regulatory Filing**: Successfully navigating the FDA NDA submission and potential approval for varegacestat.
- **Discovery & Expansion**: Using their ADC discovery platform to generate new candidates and identify and acquire targeted oncology assets to expand the portfolio. [immunome.com](https://immunome.com/about/)

## Why Work Here
- **Mission-Driven**: The work directly impacts the lives of cancer patients, with a stated goal of developing transformative therapies. [immunome.com](https://immunome.com/about/)
- **High-Impact Team**: Opportunity to work with "some of the brightest and most experienced minds in ADC development," including leaders who have brought multiple drugs to market. [immunome.com](https://immunome.com/careers/)
- **Growth Stage**: With 32 open roles, the company is in a rapid growth phase, offering significant career advancement opportunities. [job-boards.greenhouse.io](http://job-boards.greenhouse.io/immunomeinc)
- **Comprehensive Benefits**: Includes 100% company-paid medical premiums for employees, a 401(k) with employer match, paid parental leave, and a week-long winter break. [immunome.com](https://immunome.com/careers/)
- **Location & Culture**: Based in Bothell, WA. The company describes a culture of "innovative, collaborative environment where employees are empowered to do their best work." [immunome.com](https://immunome.com/careers/)

## Sources
1. [Immunome Official Website](https://immunome.com/)
2. [Immunome About Page](https://immunome.com/about/)
3. [Immunome Investor Relations](https://investors.immunome.com/)
4. [Immunome Careers Page](https://immunome.com/careers/)
5. [Immunome Jobs on Greenhouse](http://job-boards.greenhouse.io/immunomeinc)

## Other roles at Immunome, Inc.

- [Senior Manager, Clinical Project Management (Project Delivery)](https://feeny.ai/job/senior-manager-clinical-project-management-project-delivery-immunome-inc-4qv8cbmwxyhp) — Bothell Washington, United States
- [Manager, External Manufacturing Operations](https://feeny.ai/job/manager-external-manufacturing-operations-immunome-inc-bothell-washington-344kbygcy4af) — Bothell Washington, United States
- [Associate Director, Clinical Contracts Counsel](https://feeny.ai/job/associate-director-clinical-contracts-counsel-immunome-inc-united-states-e0ftbdn2a6w8) — United States
- [Director / Senior Director, External Manufacturing Operations](https://feeny.ai/job/director-senior-director-external-manufacturing-operations-immunome-inc-bothell-rkeyxhs88kwn) — Bothell Washington, United States
- [Senior Oncology Account Manager – Anticipated Opening (Product Launch)](https://feeny.ai/job/senior-oncology-account-manager-anticipated-opening-product-launch-immunome-inc-fc5qsz533qa0) — United States
- [Contract: Senior Recruiting Coordinator](https://feeny.ai/job/contract-senior-recruiting-coordinator-immunome-inc-bothell-washington-vw8zg43s3rjf) — Bothell Washington, United States
- [Principal Scientist, Analytical Development and QC, Small Molecule](https://feeny.ai/job/principal-scientist-analytical-development-and-qc-small-molecule-immunome-inc-c2et009d2yat) — Bothell Washington, United States
- [Scientist II / Senior Scientist, ADME](https://feeny.ai/job/scientist-ii-senior-scientist-adme-immunome-inc-bothell-washington-s9z30n12w0jf) — Bothell Washington, United States
- [Associate Director / Director, Clinical Science](https://feeny.ai/job/associate-director-director-clinical-science-immunome-inc-bothell-washington-494qmvx9sfw1) — Bothell Washington, United States
- [Principal Scientist, Chemical Development](https://feeny.ai/job/principal-scientist-chemical-development-immunome-inc-bothell-washington-rckdg8s8tj7r) — Bothell Washington, United States